TCMBANKIN003229 |
naphthoquinone iv |
|
C15H14O4 |
|
CC1(CCC2=C(O1)C(=O)C3=C(C2=O)C=CC=C3O)C |
TCMBANKIN005289 |
naphthoquinone ii |
|
C15H16O2 |
|
CC(=CCC1CC(=O)C2=CC=CC=C2C1=O)C |
TCMBANKIN012483 |
naphthoquinone vi |
|
C15H14O5 |
|
CC1(CC(C2=C(O1)C(=O)C3=C(C2=O)C=CC=C3O)O)C |
TCMBANKIN018117 |
catalpalactone |
W1907; MolPort-035-706-099; 3-(6,6-DIMETHYL-2-OXO-5H-PYRAN-3-YL)-3H-2-BENZOFURAN-1-ONE; AC1MHZ0W; 4CN-1548; BG01237416; CHEMBL471809; 3-(5,6-Dihydro-6,6-dimethyl-2-oxo-2H-pyran-3-yl)-1(3H)-isobenzofuranone; AKOS032948471; 1585-68-8; 1(3H)-Isobenzofuranone, 3-(5,6-dihydro-6,6-dimethyl-2-oxo-2H-pyran-3-yl)-; C16929; Catalpalactone; 133591-03-4; 3-(2,2-dimethyl-6-oxo-3H-pyran-5-yl)-3H-2-benzofuran-1-one; 1(3H)-Isobenzofuranone,3-(5,6-dihydro-6,6-dimethyl-2-oxo-2H-pyran-3-yl)-; CHEBI:80804 |
C15H14O4 |
258.27 g/mol |
CC1(CC=C(C(=O)O1)C2C3=CC=CC=C3C(=O)O2)C |
TCMBANKIN018373 |
naphthoquinone iii |
|
C15H16O3 |
|
CC1(CCC2C(O1)C(=O)C3=CC=CC=C3C2=O)C |
TCMBANKIN024182 |
lappaconitine |
|
C32H44N2O8 |
584.7 g/mol |
CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5(C6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C |
TCMBANKIN026756 |
naphthoquinone i |
|
C15H18O2 |
|
|
TCMBANKIN033789 |
naphthoquinone v |
|
C16H16O4 |
|
CC1(CCC2=C(O1)C(=O)C3=C(C2=O)C(=CC=C3)OC)C |
TCMBANKIN036853 |
catalpol |
Catalpol; LMPR01020108; beta-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-; 2415-24-9; Catalpinoside; NCGC00163523-01; beta-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy- 1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1a-alpha,1b-beta,2-beta,5a-beta,6-beta,6a-alpha))-; Catalposide, des-p-hydroxybenzoyl-; De(p-hydroxybenzoyl)catalposide; (1AS-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl-beta-D-glucopyranoside; C09773; EINECS 219-324-0 |
C15H22O10 |
362.33 |
C1=COC(C2C1C(C3C2(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O |
TCMBANKIN037430 |
alpha-Lapachone |
α-lapachone |
C15H14O3 |
242.27 |
c12c(c([H])c([H])c([H])c1[H])C(=O)C3=C(C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])O3)C2=O |
TCMBANKIN041541 |
Napiferoside |
|
|
|
|
TCMBANKIN043626 |
aucubin |
AIDS031379; 1,4a,5,7a-Tetrahydro-5-hydroxy-7-hydroxymethylcyclopenta(c)pyran-1-yl-beta-D-glucopyranoside; MEGxp0_001729; 479-98-1; AIDS-031379; Aucubin; NSC 407293; 55561_FLUKA; LMPR01020107; AKOS015965329; ZINC04098334; (1S-(1alpha,4aalpha,5alpha,7aalpha))-1,4a,5,7a-Tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta(c)pyran-1-yl-beta-D-glucopyranoside; C09771; AC-20186; ACon1_002452; (2S,3R,4S,5S,6R)-2-[[(1S,4aR,5S,7aS)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; EINECS 207-540-8; (2S,3R,4S,5S,6R)-2-((1S,4aR,5R,7aS)-5-Hydroxy-7-hydroxymethyl-1,4a,5,7a-tetrahydro-cyclopenta[c]pyran-1-yloxy)-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[[(1S,4aR,5S,7aS)-5-hydroxy-7-methylol-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[[(1S,4aR,5S,7aS)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol |
C15H22O10 |
362.329 |
[C@@]12([H])[C@@]([H])(C(C([H])([H])O[H])=C([H])[C@@]1([H])O[H])[C@]([H])(OO[C@@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])OC([H])=C2[H] |